Genetic Biomarkers of Paracetamol (Acetaminophen)-Induced Acute Liver Failure
-
Published:2016
Issue:
Volume:
Page:1-27
-
ISSN:2451-9766
-
Container-title:Biomarkers in Disease: Methods, Discoveries and Applications
-
language:
-
Short-container-title:
Publisher
Springer Netherlands
Reference85 articles.
1. Adukauskiene D, Dockiene I, Naginiene R, Kevelaitis E, Pundzius J, Kupcinskas L. Acute liver failure in Lithuania. Medicina (Kaunas). 2008;44:536–40.
2. Ameer B, Greenblatt DJ. Acetaminophen. Ann Intern Med. 1977;87:202–9.
3. Bailey DN, Briggs JR. The binding of selected therapeutic drugs to human serum alpha-1 acid glycoprotein and to human serum albumin in vitro. Ther Drug Monit. 2004;26:40–3.
4. Bernal W, Donaldson P, Underhill J, Wendon J, Williams R. Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure. J Hepatol. 1998;29:53–9.
5. Boess F, Bopst M, Althaus R, Polsky S, Cohen SD, Eugster HP, Boelsterli UA. Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-alpha gene knockout mice. Hepatology. 1998;27:1021–9.